In October 2025, the group successfully launched Tadalafil Tablets, offering a long-acting treatment option for ED patients. This milestone reflects the company’s growing formulation expertise and market expansion strategy.

2026-03-31 18:44
share
WeChat
Sina Weibo
QQ
QQ space
Douban
Baidu Post Bar
Prev Jitai will exhibit at CPHI China 2025, the 23rd World Pharmaceutical Raw Materials Exhibition, held from June 24–26, 2025, at the Shanghai New International Expo Center. The event provides a platform to showcase advanced manufacturing capabilities and engage with international partners.
Next Yangling Jitai Pharmaceutical Makes Debut at the 23rd China International Pharmaceutical Ingredients Expo, Driving Global Pharma Collaboration with Innovation
提示文案